Glypican 2 As A Cancer Marker And Therapeutic Target
Technology
E-285-2016
Patent ID
E-285-2016-2-US-01
Country
US
Application Type
DIV
Patent Status
Pending
Patent Number
Publication Number
US-2024-0084034-A1
Application Number
18/499,054
IC
NCI
Date Filed
Date Issued
Patent PDF